Navigation Links
Centocor R&D and University of Michigan Forge New Model for Academic/Industry Partnerships
Date:3/19/2009

MALVERN, Pa. March 19 /PRNewswire/ -- A new joint program launched by Centocor Research and Development, Inc. and the University of Michigan provides an innovative model for industry/academic fellowship programs. Centocor designed the program to continue to build and diversify the company's pipeline of talent while supporting postdoctoral researchers in populations that are traditionally underrepresented in the science and medical communities.

"Scientific excellence and diversity are key drivers for our success as a global pharmaceutical organization. Partnering with a leading research organization to foster the training of the next generation of scientific leaders is a key part of our strategy," said Miguel Barbosa, Ph.D., vice president, Discovery Research at Centocor R&D.

The program aims to forge strong relationships with African American, Hispanic, and Native American scientists who are working in the strategic areas of focus for Centocor.

"We believe the direct ties to our research interests make this program more strategic and collaborative than traditional industry/academic fellowship programs," Barbosa said. "This strategic link will help us build strong relationships with these talented individuals thus creating a robust pipeline of potential hires."

Under the program, research proposals developed jointly by University of Michigan and Centocor scientists are submitted to and reviewed by a joint committee of Centocor and Michigan representatives, who will select projects and evaluate their progress. Postdoctoral fellows recruited by the University of Michigan have the opportunity to work at both the University and at the Centocor campus and to work through scientific challenges with a mentor at each location.

Centocor R&D selected the University of Michigan with which to pilot the program, based on the high level of productivity past research collaborations have yielded, and may expand the program in the coming years to other academic partners.

Barbosa said, "We look forward to nurturing the development of underrepresented minority post doctoral trainees from University of Michigan and potentially other top-tier research organizations into the next generation of scientific leaders."

About Centocor Research and Development, Inc.

Centocor is dedicated to the research and development of treatments for a wide range of immune-mediated inflammatory disorders, such as arthritis, and inflammatory skin diseases, and for cancer, cardiovascular and metabolic and infectious diseases. Developed primarily through monoclonal antibody technology, Centocor helps physicians deliver innovative treatments to improve human health and restore patients' quality of life.


'/>"/>
SOURCE Centocor Research and Development, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. FASgen, Inc. Announces Research and License Agreement With Centocor, Inc.
2. Biologic Drugs, Particularly Centocor/Janssen-Cilags Stelara and Abbott/Eisais Humira, will Drive the Psoriasis Drug Market to $5 Billion by 2017
3. MEDVERSATION(TM) Website Launched by Centocor to Facilitate Physician-Patient Dialogue About Drug Benefits and Risks
4. Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
5. Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab
6. Western Governors University Addresses Rising Demand for Healthcare IT Professionals with B.S. in Health Informatics
7. DeVry University announces Employment Gap Scholarship program to aid displaced workers
8. University of Notre Dame Chooses Latest Technology From Carestream Molecular Imaging For Disease Research
9. University of Pennsylvania researchers find that the unexpected is a key to human learning
10. NorthShore University HealthSystem Launches Diabetes Outreach Program for Lake County's Medically Underserved
11. Dallas To Host Intensive Norvax University Insurance Agent Sales Training and Web Marketing Conference on March 26
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 2017 , ... The Radiology Business Management Association (RBMA) is pleased ... new executive director. Mr. Still was selected through a careful months-long search by the ... is known to our members, has been a part of building the RBMA since ...
(Date:3/28/2017)... ... 28, 2017 , ... Award-winning medical group Allied Anesthesia today ... board chair for Orange County health care system CalOptima Friday. CalOptima announced its ... chair Mark Refowitz’s term, which runs through June 30 of this year, until ...
(Date:3/28/2017)... Lithuania (PRWEB) , ... March 28, 2017 , ... ... technologies, today announced the release of two biometric time and attendance tracking products: ... Attendance 4.0 software. NCheck Cloud Bio Attendance uses biometric face recognition to ...
(Date:3/28/2017)... ... March 28, 2017 , ... METTLER TOLEDO Process Analytics is ... plant water and steam. , Chlorides and sulfates cause pitting and stress corrosion ... maintenance and unplanned shutdowns. Monitoring these ions at low ppb levels has therefore ...
(Date:3/28/2017)... ... ... The Executives, Staff & Clients of MGE: Management Experts joined forces with ... Campaign at their Semi-Annual Graduation and Fundraiser Event at MGE’s St. Petersburg Office. , ... 14 internationally in literacy. Statistically, a direct relation can be a found between illiteracy ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... -- The global flow cytometry market ... 2025, according to a new study by Grand View ... cancer is expected to upsurge the demand for flow ... years. In addition, higher number of physicians is inclined ... therapy, due to adverse effects caused by chemotherapy & ...
(Date:3/27/2017)... 2017 Summary This report ... and its partnering interests and activities since 2010. Description ... in-depth insight into the partnering activity of one of the ... reports are prepared upon purchase to ensure inclusion of the ... The report will be delivered in PDF format within 1 ...
(Date:3/27/2017)... 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology ... toxicology and efficacy studies. The company is harnessing the ... protein, MAGE A, in an effort to find a ... After 4 weeks of treatment in transgenic mice, ... toxicity in a full toxicology report of various organs. ...
Breaking Medicine Technology: